Ozempic and similar drugs are increasingly used for treating type 2 diabetes in Cayman. However, their popularity as weight-loss tools locally and globally has caused a shortage of the medication for diabetics.
These injectable drugs, known as semaglutides, effectively lower glucose levels and suppress the appetite, becoming a popular diet trend.
According to Dr. Fiona Robertson, these drugs work by keeping food in the stomach for longer, leading to a feeling of fullness. They also alter appetite and preference for starchy foods while modifying the storage of sugars in the liver.
Originally designed for diabetes treatment, Ozempic and Wegovy have gained FDA approval for weight management as well.
However, it’s important to note that the drug doesn’t work for everyone, and it’s not a quick fix. Proper medical counselling and adjustments in diet are essential for success.
The appetite suppressant qualities of these drugs have led to their use as weight-loss aids by people who are not obese. Concerns arise from some users not being aware of potential side effects, such as nausea, stomach discomfort, bloating and vomiting.
Despite its benefits, the long-term effects of weight loss with these drugs remain uncertain. Nutritionists highlight the importance of healthy eating and lifestyle habits for sustainable results.
Though effective, Ozempic and similar drugs are expensive, and insurance companies in Cayman usually cover them only for diabetic patients.
Ultimately, these drugs have the potential to change the management of type 2 diabetes, but their widespread use for weight loss has led to shortages, raising concerns about access for diabetic patients.
